Adverse Event Clinical Research
1.0.1 - STU1

Adverse Event Clinical Research, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-ig/ and changes regularly. See the Directory of published versions

## MedicationRequest: Medication Request for discontinued clinical trial medication 0301

Page standards status: Informative

Generated Narrative: MedicationRequest

Resource MedicationRequest "medicationrequest0301-discontinue"

identifier: `http://www.bmc.nl/portal/medstatements`/med0301-studyDrug (use: official)

status: stopped

intent: order

### Medications

- | Reference
* | code: Study Medication for psoriasis ()

subject: Patient/ClinicalTrialSubject5 " CLINICAL TRIAL"

authoredOn: 1905-08-23

requester: : Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD

### Reasons

- | Concept
* | Psoriasis (SNOMED CT#9014002)

### DosageInstructions

- | Text | Route | Method
* | 500mg IV q6h x 3 days | Intravenous route (qualifier value) (SNOMED CT#47625008) | IV Push ()

> Generated Narrative: Medication #med0301

> code: Study Medication for psoriasis ()